Company Genkyotex CBOE EUROPE EQUITIES
Equities
FR0011790542
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
2021 | Calliditas Therapeutics : Acquires Remaining Stake in Genkyotex | MT |
2021 | Genkyotex SA(ENXTPA:GKTX) dropped from CAC AllShares Index | CI |
Business Summary
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 20/01/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,083,408 | 589,683 ( 4.187 %) | 9,243 ( 0.0656 %) | 4.187 % |
Company contact information
Calliditas Therapeutics France SAS
218 avenue Marie Curie Forum 2 – Archparc
74160, Archamps
+
http://www.calliditas.seSector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.39% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- GKTX Stock
- Stock
- Company Genkyotex